GB0104422D0 - Quinoline derivative - Google Patents

Quinoline derivative

Info

Publication number
GB0104422D0
GB0104422D0 GB0104422A GB0104422A GB0104422D0 GB 0104422 D0 GB0104422 D0 GB 0104422D0 GB 0104422 A GB0104422 A GB 0104422A GB 0104422 A GB0104422 A GB 0104422A GB 0104422 D0 GB0104422 D0 GB 0104422D0
Authority
GB
United Kingdom
Prior art keywords
quinoline derivative
quinoline
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0104422A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0104422A priority Critical patent/GB0104422D0/en
Publication of GB0104422D0 publication Critical patent/GB0104422D0/en
Priority to PCT/GB2002/000803 priority patent/WO2002068394A1/en
Ceased legal-status Critical Current

Links

GB0104422A 2001-02-22 2001-02-22 Quinoline derivative Ceased GB0104422D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0104422A GB0104422D0 (en) 2001-02-22 2001-02-22 Quinoline derivative
PCT/GB2002/000803 WO2002068394A1 (en) 2001-02-22 2002-02-22 Quinoline derivative as tyrosine kinase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0104422A GB0104422D0 (en) 2001-02-22 2001-02-22 Quinoline derivative

Publications (1)

Publication Number Publication Date
GB0104422D0 true GB0104422D0 (en) 2001-04-11

Family

ID=9909309

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0104422A Ceased GB0104422D0 (en) 2001-02-22 2001-02-22 Quinoline derivative

Country Status (2)

Country Link
GB (1) GB0104422D0 (en)
WO (1) WO2002068394A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
EP1924262B1 (en) 2005-08-22 2011-11-16 Melior Pharmaceuticals I, Inc. Methods and formulations for modulating lyn kinase activity and treating related disorders
CN101686686A (en) * 2007-02-20 2010-03-31 梅里奥尔医药I公司 methods of identifying activators of lyn kinase
KR101257158B1 (en) 2008-05-23 2013-04-23 노파르티스 아게 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011140442A1 (en) * 2010-05-07 2011-11-10 Glaxo Group Limited Amino-quinolines as kinase inhibitors
CA2829131C (en) 2011-03-04 2018-11-20 Glaxosmithkline Intellectual Property (No.2) Limited Amino-quinolines as kinase inhibitors
TWI547494B (en) 2011-08-18 2016-09-01 葛蘭素史克智慧財產發展有限公司 Amino quinazolines as kinase inhibitors
AR092529A1 (en) 2012-09-13 2015-04-22 Glaxosmithkline Llc AMINOQUINAZOLINE COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE OF THIS COMPOSITE FOR THE PREPARATION OF A MEDICINAL PRODUCT
AR092530A1 (en) 2012-09-13 2015-04-22 Glaxosmithkline Llc AMINO-QUINOLINE COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE OF THIS COMPOUND FOR THE PREPARATION OF A MEDICINAL PRODUCT
KR20150118152A (en) 2013-02-21 2015-10-21 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Quinazolines as kinase inhibitors
SG11201909406VA (en) 2017-04-10 2019-11-28 Melior Pharmaceuticals I Inc Treatment of adipocytes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
AU733551B2 (en) * 1996-09-25 2001-05-17 Astrazeneca Ab Qinoline derivatives inhibiting the effect of growth factors such as VEGF
SK12112001A3 (en) * 1999-02-27 2001-12-03 Boehringer Ingelheim Pharma Kg 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases

Also Published As

Publication number Publication date
WO2002068394A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
HK1061810A1 (en) Tetrahydroquinoline derivatives
HUP0700124A2 (en) Quinoline compound
IL154618A0 (en) Quinolinone derivatives
EP1450801A4 (en) 2-aminoquinoline compounds
IL175947A0 (en) Novel quinoline derivatives
ZA200309522B (en) Substituted cyclohexane-1-4diamine derivatives
HRP20041031A2 (en) Quinolinone derivatives
HK1068608A1 (en) 3-Substituted-4-pyrimidone derivatives
IL158388A0 (en) Novel arylheteroalkylamine derivatives
PL376997A1 (en) Tetrahydroquinoline derivatives
GB0108968D0 (en) Methods
HUP0303449A3 (en) Substituted benzofuran-2-carboxamides derivatives
AU2002347336A1 (en) Quinoline derivatives
HK1068607A1 (en) Phenylalkyloxy-phenyl derivatives
PL377318A1 (en) Tetrahydroquinoline derivatives
HUP0303186A3 (en) 4-aminobenzopyran derivatives
GB0104422D0 (en) Quinoline derivative
HUP0401949A3 (en) 4-imidazolin-2-one derivatives
AU2002347359A1 (en) Quinoline derivatives
HK1071364A1 (en) Quinoline derivatives
HUP0500026A3 (en) N-heteroarylnicotinamide derivatives
GB0111146D0 (en) Methods
GB0116249D0 (en) Methods
EP1364954A4 (en) Dicarba-closo-dodecarborane derivatives
GB0116076D0 (en) Methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)